Altimmune, Inc. (ALT) Tops Q3 EPS by 1c

Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.48), $0.01 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $2 thousand versus the consensus estimate of $867.83 thousand.

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• MotorK names Roy Toren to board as Helen Protopapas resigns
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan